Rapid and unequivocal differentiation of Candida dubliniensis from other Candida species using species-specific DNA probes: comparison with phenotypic identification methods.

Candida dubliniensis is a recently described opportunistic pathogen which shares many phenotypic characteristics with Candida albicans but which has been reported to rapidly acquire resistance to azole antifungal drugs. Therefore, differentiation of C. dubliniensis from C. albicans becomes important to better understand the clinical significance and epidemiologic role of C. dubliniensis in candidiasis. We compared phenotypic methods for the differentiation of C. dubliniensis from C. albicans (i.e. the ability to grow at elevated temperatures, colony color on CHROMagar Candida medium, and carbohydrate assimilation patterns) to amplify the results of a polymerase chain reaction (PCR) assay using universal fungal primers to the internal transcribed spacer 2 (ITS2) region of rDNA and species-specific DNA probes in an enzyme immunoassay format (PCR-EIA). DNA sequencing of the ITS1 rDNA region was also conducted. The C. dubliniensis ITS2 probe correctly identified all C. dubliniensis isolates without cross-reaction with any other Candida species tested (mean A(650 nm) +/- SE, C. dubliniensis probe with C. dubliniensis DNA, 0.372 +/- 0.01, n = 22; C. dubliniensis probe with other Candida species DNA, 0.001 +/- 0.02 n = 16, P < 0.001). All other Candida species tested (C. albicans, Candida glabrata, Candida krusei, Candida parapsilosis, and Candida tropicalis) were also correctly identified by the PCR-EIA without any detectable cross-reactions among species. Phenotypically, C. dubliniensis isolates demonstrated an increased sensitivity to heat compared to C. albicans isolates. At 42 degrees C, only 50% of C. dubliniensis isolates grew compared to 73% of C. albicans isolates and, at 45 degrees C, 91% of C. dubliniensis isolates failed to grow compared to 64% of C. albicans isolates. C. albicans was more likely to demonstrate a dark green or blue green colony color on CHROMagar Candida medium obtained from Becton Dickinson (i.e. 100% of C. albicans isolates were dark green or blue green versus 64% of C. dubliniensis isolates) whereas no difference in the percentage of C. albicans or C. dubliniensis isolates producing dark green or blue green colony color was detected using CHROMagar Candida medium from Hardy Diagnostics (82% for both species). The API 20C AUX carbohydrate assimilation system incorrectly identified C. dubliniensis as C. albicans in all but three cases: remaining isolates were misidentified as C. albicans/C. tropicalis, C. tropicalis/C. albicans, and Candida lusitaniae/C. albicans. In all, 82% of C. albicans isolates and 100% of C. dubliniensis isolates assimilated trehalose; the latter finding was opposite to that reported for C. dubliniensis in the API 20C AUX profile index. Xylose and alpha-methyl-D-glucoside assimilation, respectively, were negative for 100 and 95% of C. dubliniensis isolates and positive for 100 and 91% of C. albicans isolates, confirming earlier reports that assimilation results for xylose and alpha-methyl-D-glucoside may be helpful in the discrimination of these two species. However, conventional phenotypic species identification tests required days for completion, whereas the PCR-EIA could be completed in a matter of hours. In addition, identification of Candida species by ITS1 rDNA sequencing gave 100% correspondence to the results obtained by the PCR-EIA, confirming the specificity of the PCR-EIA method. These data indicate that although a combination of phenotypic methods may help differentiate C. dubliniensis from C. albicans to some extent, the PCR-EIA can provide a simple, rapid, and unequivocal identification of the most medically important Candida species in a single test.

[1]  S. Kwok,et al.  Avoiding false positives with PCR , 1989, Nature.

[2]  T. Lott,et al.  Microtitration plate enzyme immunoassay to detect PCR-amplified DNA from Candida species in blood , 1995, Journal of clinical microbiology.

[3]  D. Coleman,et al.  Candida dubliniensis candidaemia in an HIV-positive patient in Ireland , 2002, International journal of STD & AIDS.

[4]  J. Kellogg,et al.  Limitations of the Current Microbial Identification System for Identification of Clinical Yeast Isolates , 1998, Journal of Clinical Microbiology.

[5]  W. Siegert,et al.  Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. , 1999, Emerging infectious diseases.

[6]  D. Soll,et al.  Identification of Candida dubliniensis Based on Temperature and Utilization of Xylose and α-Methyl-d-Glucoside as Determined with the API 20C AUX and Vitek YBC Systems , 1999, Journal of Clinical Microbiology.

[7]  R. Gaynes,et al.  Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  D. Soll,et al.  Identification of Four Distinct Genotypes of Candida dubliniensis and Detection of Microevolution In Vitro and In Vivo , 2002, Journal of Clinical Microbiology.

[9]  S. Porter,et al.  The isolation, identification and molecular analysis of Candida spp. isolated from the oral cavities of patients with diabetes mellitus. , 2002, Oral microbiology and immunology.

[10]  G. Haase,et al.  Recovery of Candida dubliniensis from sputum of cystic fibrosis patients , 2002, Mycoses.

[11]  J. Wingard,et al.  Importance of Candida species other than C. albicans as pathogens in oncology patients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  M. Mallié,et al.  Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities , 1995, Journal of clinical microbiology.

[13]  M. Addo,et al.  Cluster of oral atypical Candida albicans isolates in a group of human immunodeficiency virus-positive drug users , 1995, Journal of clinical microbiology.

[14]  S. Donnelly,et al.  Recovery of Candida dubliniensisfrom Non-Human Immunodeficiency Virus-Infected Patients in Israel , 2000, Journal of Clinical Microbiology.

[15]  K. Nishimura,et al.  Isolation of Candida dubliniensis from the oral cavity of an HIV-positive child in Brazil. , 2000, Nihon Ishinkin Gakkai zasshi = Japanese journal of medical mycology.

[16]  G. Moran,et al.  Candidiasis: the emergence of a novel species, Candida dubliniensis , 1997, AIDS.

[17]  P. Reade,et al.  Characterization of genetically distinct subgroup of Candida albicans strains isolated from oral cavities of patients infected with human immunodeficiency virus , 1995, Journal of clinical microbiology.

[18]  L. Harrison,et al.  Candida dubliniensis fungemia: the first four cases in North America. , 2000, Emerging infectious diseases.

[19]  J. Fell,et al.  Rapid detection and identification of pathogenic fungi by polymerase chain reaction amplification of large subunit ribosomal DNA. , 1995, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[20]  A. Padhye,et al.  Rapid Identification of Candida dubliniensis with Commercial Yeast Identification Systems , 1999, Journal of Clinical Microbiology.

[21]  M. Mallié,et al.  Atypical strains of Candida albicans recovered from AIDS patients. , 1997, Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology.

[22]  D. Soll,et al.  In Vitro Susceptibilities of Candida dubliniensisIsolates Tested against the New Triazole and Echinocandin Antifungal Agents , 1999, Journal of Clinical Microbiology.

[23]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[24]  N. Cimolai,et al.  Candida dubliniensis fungemia and vascular access infection. , 2002, Journal of pediatric hematology/oncology.

[25]  G. Lemay,et al.  A novel group I intron in Candida dubliniensis is homologous to a Candida albicans intron. , 1996, Gene.

[26]  M. Henman,et al.  Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. , 1997, Oral diseases.

[27]  F. Odds,et al.  CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species , 1994, Journal of clinical microbiology.

[28]  E. Anaissie,et al.  Importance of Candida species other than Candida albicans as opportunistic pathogens. , 1998, Medical mycology.

[29]  O. Kurzai,et al.  Rapid PCR Test for Discriminating betweenCandida albicans and Candida dubliniensisIsolates Using Primers Derived from the pH-Regulated PHR1and PHR2 Genes of C. albicans , 1999, Journal of Clinical Microbiology.

[30]  T. Lott,et al.  Rapid Identification of Candida Species with Species-Specific DNA Probes , 1998, Journal of Clinical Microbiology.

[31]  R. Anthony,et al.  Multiple strains of Candida albicans in the oral cavity of HIV positive and HIV negative patients , 1994 .

[32]  G. Gottlieb,et al.  Candida dubliniensis fungemia in a solid organ transplant patient: case report and review of the literature. , 2001, Medical mycology.

[33]  S. Sanche,et al.  Detection of Candida dubliniensis in Oropharyngeal Samples from Human Immunodeficiency Virus-Infected Patients in North America by Primary CHROMagar Candida Screening and Susceptibility Testing of Isolates , 1998, Journal of Clinical Microbiology.

[34]  S. Donnelly,et al.  Identification and Expression of Multidrug Transporters Responsible for Fluconazole Resistance in Candida dubliniensis , 1998, Antimicrobial Agents and Chemotherapy.

[35]  M. Henman,et al.  Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro , 1997, Antimicrobial agents and chemotherapy.

[36]  H. Goossens,et al.  Use of specialised isolation media for recognition and identification ofCandida dubliniensis isolates from HIV-infected patients , 1997, European Journal of Clinical Microbiology and Infectious Diseases.

[37]  R. Kuykendall,et al.  Nucleotide sequence analysis of the 5·8S rDNA and adjacent ITS2 region of Candida albicans and related species , 1993, Yeast.

[38]  L. J. Wickerham,et al.  Carbon Assimilation Tests for the Classification of Yeasts , 1948, Journal of bacteriology.

[39]  W. Merz,et al.  Identification of Candida dubliniensisin a Prospective Study of Patients in the United States , 1999, Journal of Clinical Microbiology.

[40]  D. Sullivan,et al.  Simple, Inexpensive, Reliable Method for Differentiation of Candida dubliniensis fromCandida albicans , 1998, Journal of Clinical Microbiology.

[41]  D. Coleman,et al.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. , 1995, Microbiology.

[42]  M. Romagnoli,et al.  Evaluation of a Reformulated CHROMagar Candida , 2001, Journal of Clinical Microbiology.

[43]  D. Stevens,et al.  Molecular and Phenotypic Characterization of Genotypic Candida albicans Subgroups and Comparison withCandida dubliniensis and Candida stellatoidea , 1999, Journal of Clinical Microbiology.

[44]  F. Nolte,et al.  Rapid identification of Candida species in blood cultures by a clinically useful PCR method , 1997, Journal of clinical microbiology.

[45]  S. Donnelly,et al.  Phylogenetic analysis and rapid identification of Candida dubliniensis based on analysis of ACT1 intron and exon sequences. , 1999, Microbiology.

[46]  D. Sullivan,et al.  Candida dubliniensis: Characteristics and Identification , 1998, Journal of Clinical Microbiology.

[47]  Michael Seibold,et al.  Evaluation of Phenotypic Markers for Selection and Identification of Candida dubliniensis , 2000, Journal of Clinical Microbiology.

[48]  T. Lott,et al.  Sequence Analysis of the Internal Transcribed Spacer 2 (ITS2) from Yeast Species Within the Genus Candida , 1998, Current Microbiology.